Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407
Diabetes Care
.
2020 Oct;43(10):e163-e164.
doi: 10.2337/dc20-1205.
Authors
Bertrand Cariou
1
,
Samy Hadjadj
2
,
Matthieu Wargny
2
3
,
Matthieu Pichelin
2
,
Pierre Gourdy
4
Affiliations
1
L'institut du thorax, CHU Nantes, CNRS, Inserm, Université de Nantes, Nantes, France bertrand.cariou@univ-nantes.fr.
2
L'institut du thorax, CHU Nantes, CNRS, Inserm, Université de Nantes, Nantes, France.
3
Clinique des Données, CHU Nantes, CIC Inserm 1413, Nantes, France.
4
CHU de Toulouse and UMR1048/I2MC, Université de Toulouse, Toulouse, France.
PMID:
32958626
PMCID:
PMC7510026
DOI:
10.2337/dc20-1205
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Diabetes Mellitus*
Glucose
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Substances
Glucose